Skip to main content
Top
Published in: Journal of Genetic Counseling 2/2013

01-04-2013 | Original Research

“Grasping the Grey”: Patient Understanding and Interpretation of an Intermediate Allele Predictive Test Result for Huntington Disease

Authors: A. Semaka, L. G. Balneaves, M. R. Hayden

Published in: Journal of Genetic Counseling | Issue 2/2013

Login to get access

Abstract

Since the discovery of the genetic mutation underlying Huntington disease (HD) and the development of predictive testing, the genetics of HD has generally been described as straightforward; an individual receives either mutation-positive or negative predictive test results. However, in actuality, the genetics of HD is complex and a small proportion of individuals receive an unusual predictive test result called an intermediate allele (IA). Unlike mutation-positive or negative results, IAs confer uncertain clinical implications. While individuals with an IA will usually not develop HD, there remains an unknown risk for their children and future generations to develop the disorder. The purpose of this study was to explore how individuals understood and interpreted their IA result. Interviews were conducted with 29 individuals who received an IA result and 8 medical genetics service providers. Interviews were analyzed using the constant comparative method and the coding procedures of grounded theory. Many participants had difficulty “Grasping the Grey” (i.e. understanding and interpreting their IA results) and their family experience, beliefs, expectations, and genetic counseling influenced the degree of this struggle. The theoretical model developed informs clinical practice regarding IAs, ensuring that this unique subset of patients received appropriate education, support, and counseling.
Appendix
Available only for authorised users
Literature
go back to reference Almqvist, E. W., Elterman, D. S., MacLeod, P. M., & Hayden, M. R. (2001). High incidence rate and absent family histories in one quarter of patients newly diagnosed with Huntington disease in British Columbia. Clinical Genetics, 60(3), 198–205.PubMedCrossRef Almqvist, E. W., Elterman, D. S., MacLeod, P. M., & Hayden, M. R. (2001). High incidence rate and absent family histories in one quarter of patients newly diagnosed with Huntington disease in British Columbia. Clinical Genetics, 60(3), 198–205.PubMedCrossRef
go back to reference Andrich, J., Arning, L., Wieczorek, S., Kraus, P. H., Gold, R., & Saft, C. (2008). Huntington’s disease as caused by 34 CAG repeats. Movement Disorders, 23(6), 879–881.PubMedCrossRef Andrich, J., Arning, L., Wieczorek, S., Kraus, P. H., Gold, R., & Saft, C. (2008). Huntington’s disease as caused by 34 CAG repeats. Movement Disorders, 23(6), 879–881.PubMedCrossRef
go back to reference Aubeeluck, A., & Moskowitz, C. (2008). Huntington’s disease. Part 3: family aspects of HD. British Journal of Nursing, 17(5), 328.PubMedCrossRef Aubeeluck, A., & Moskowitz, C. (2008). Huntington’s disease. Part 3: family aspects of HD. British Journal of Nursing, 17(5), 328.PubMedCrossRef
go back to reference Balneaves, L. G., Truant, T. L. O., Kelly, M., Verhoef, M. J., & Davison, B. J. (2007). Bridging the gap: decision-making processes of women with breast cancer using complementary and alternative medicine. Support Care Cancer, 15(8), 973–983.PubMedCrossRef Balneaves, L. G., Truant, T. L. O., Kelly, M., Verhoef, M. J., & Davison, B. J. (2007). Bridging the gap: decision-making processes of women with breast cancer using complementary and alternative medicine. Support Care Cancer, 15(8), 973–983.PubMedCrossRef
go back to reference Beeson, D. (1997). Nuance, complexity, and context: qualitative methods in genetic counseling research. Journal of Genetic Counseling, 6(1), 21–43.CrossRefPubMed Beeson, D. (1997). Nuance, complexity, and context: qualitative methods in genetic counseling research. Journal of Genetic Counseling, 6(1), 21–43.CrossRefPubMed
go back to reference Bish, A., Sutton, S., Jacobs, C., Levene, S., Ramirez, A., & Hodgson, S. (2002). No news is (not necessarily) good news: impact of preliminary results for BRCA1 mutation searches. Genetics in Medicine, 4(5), 353–358.CrossRef Bish, A., Sutton, S., Jacobs, C., Levene, S., Ramirez, A., & Hodgson, S. (2002). No news is (not necessarily) good news: impact of preliminary results for BRCA1 mutation searches. Genetics in Medicine, 4(5), 353–358.CrossRef
go back to reference Chong, S. S., Almqvist, E., Telenius, H., LaTray, L., Nichol, K., Bourdelat-Parks, B., et al. (1997). Contribution of DNA sequence and CAG size to mutation frequencies of intermediate alleles for Huntington disease: evidence from single sperm analyses. Human Molecular Genetics, 6(2), 301–309.PubMedCrossRef Chong, S. S., Almqvist, E., Telenius, H., LaTray, L., Nichol, K., Bourdelat-Parks, B., et al. (1997). Contribution of DNA sequence and CAG size to mutation frequencies of intermediate alleles for Huntington disease: evidence from single sperm analyses. Human Molecular Genetics, 6(2), 301–309.PubMedCrossRef
go back to reference Corbin, J., & Strauss, A. (1990). Grounded theory research: procedures, canons, and evaluative criteria. Qualitative Sociology, 13(1), 3–21.CrossRef Corbin, J., & Strauss, A. (1990). Grounded theory research: procedures, canons, and evaluative criteria. Qualitative Sociology, 13(1), 3–21.CrossRef
go back to reference Cox, S. (2003). Stories in decisions: how at-risk individuals decide to request predictive testing for Huntington disease. Qualitative Sociology, 26(2), 257–280.CrossRef Cox, S. (2003). Stories in decisions: how at-risk individuals decide to request predictive testing for Huntington disease. Qualitative Sociology, 26(2), 257–280.CrossRef
go back to reference Cox, S., & McKellin, W. (2001). ‘There’s this thing in our family’: predictive testing and the construction of risk for Huntington Disease. Sociology of Health & Illness, 21(5), 622–646.CrossRef Cox, S., & McKellin, W. (2001). ‘There’s this thing in our family’: predictive testing and the construction of risk for Huntington Disease. Sociology of Health & Illness, 21(5), 622–646.CrossRef
go back to reference Creighton, S., Almqvist, E. W., MacGregor, D., Fernandez, B., Hogg, H., Beis, J., et al. (2003). Predictive, pre-natal and diagnostic genetic testing for Huntington's disease: the experience in Canada from 1987 to 2000. Clinical Genetics, 63(6), 462–475.PubMedCrossRef Creighton, S., Almqvist, E. W., MacGregor, D., Fernandez, B., Hogg, H., Beis, J., et al. (2003). Predictive, pre-natal and diagnostic genetic testing for Huntington's disease: the experience in Canada from 1987 to 2000. Clinical Genetics, 63(6), 462–475.PubMedCrossRef
go back to reference Etchegary, H. (2006). Discovering the family history of Huntington Disease (HD). Journal of Genetic Counseling, 15(2), 105–117.PubMedCrossRef Etchegary, H. (2006). Discovering the family history of Huntington Disease (HD). Journal of Genetic Counseling, 15(2), 105–117.PubMedCrossRef
go back to reference Falush, D., Almqvist, E. W., Brinkmann, R. R., Iwasa, Y., & Hayden, M. R. (2001). Measurement of mutational flow implies both a high new-mutation rate for Huntington disease and substantial underascertainment of late-onset cases. American Journal of Human Genetics, 68(2), 373–385.PubMedCrossRef Falush, D., Almqvist, E. W., Brinkmann, R. R., Iwasa, Y., & Hayden, M. R. (2001). Measurement of mutational flow implies both a high new-mutation rate for Huntington disease and substantial underascertainment of late-onset cases. American Journal of Human Genetics, 68(2), 373–385.PubMedCrossRef
go back to reference Festinger, L. (1964). Conflict, decision and dissonance. Stanford: Stanford University Press. Festinger, L. (1964). Conflict, decision and dissonance. Stanford: Stanford University Press.
go back to reference Forrest Keenan, K. (2009). How young people find out about their family history of Huntington’s disease. Social Science & Medicine, 68(10), 1892–1900.CrossRef Forrest Keenan, K. (2009). How young people find out about their family history of Huntington’s disease. Social Science & Medicine, 68(10), 1892–1900.CrossRef
go back to reference Forrest Keenan, K., Miedzybrodzka, Z., Van Teijlingen, E., Mckee, L., & Simpson, S. (2007). Young people’s experiences of growing up in a family affected by Huntington’s disease. Clinical Genetics, 71(2), 120–129.PubMedCrossRef Forrest Keenan, K., Miedzybrodzka, Z., Van Teijlingen, E., Mckee, L., & Simpson, S. (2007). Young people’s experiences of growing up in a family affected by Huntington’s disease. Clinical Genetics, 71(2), 120–129.PubMedCrossRef
go back to reference Goldberg, Y. P., Kremer, B., Andrew, S. E., Theilmann, J., Graham, R. K., Squitieri, F., et al. (1993). Molecular analysis of new mutations for Huntington’s disease: intermediate alleles and sex of origin effects. Nature Genetics, 5(2), 174–179.PubMedCrossRef Goldberg, Y. P., Kremer, B., Andrew, S. E., Theilmann, J., Graham, R. K., Squitieri, F., et al. (1993). Molecular analysis of new mutations for Huntington’s disease: intermediate alleles and sex of origin effects. Nature Genetics, 5(2), 174–179.PubMedCrossRef
go back to reference Goldberg, Y. P., McMurray, C. T., Zeisler, J., Almqvist, E., Sillence, D., Richards, R., et al. (1995). Increased instability of intermediate alleles in families with sporadic Huntington disease compared to similar sized intermediate alleles in the general population. Human Molecular Genetics, 4(10), 1911–8.PubMedCrossRef Goldberg, Y. P., McMurray, C. T., Zeisler, J., Almqvist, E., Sillence, D., Richards, R., et al. (1995). Increased instability of intermediate alleles in families with sporadic Huntington disease compared to similar sized intermediate alleles in the general population. Human Molecular Genetics, 4(10), 1911–8.PubMedCrossRef
go back to reference Groen, J. L., de Bie, R. M. A., Foncke, E. M. J., Roos, R. A. C., Leenders, K. L., & Tijssen, M. A. J. (2010). Late-onset Huntington disease with intermediate CAG repeats: true or false? Journal of Neurology, Neurosurgery, and Psychiatry, 81(2), 228–230.PubMedCrossRef Groen, J. L., de Bie, R. M. A., Foncke, E. M. J., Roos, R. A. C., Leenders, K. L., & Tijssen, M. A. J. (2010). Late-onset Huntington disease with intermediate CAG repeats: true or false? Journal of Neurology, Neurosurgery, and Psychiatry, 81(2), 228–230.PubMedCrossRef
go back to reference Grover, S. (2003). The psychological dimension of informed consent: dissonance processes in genetic testing. Journal of Genetic Counseling, 12(5), 389–403.PubMedCrossRef Grover, S. (2003). The psychological dimension of informed consent: dissonance processes in genetic testing. Journal of Genetic Counseling, 12(5), 389–403.PubMedCrossRef
go back to reference Grubs, R., & Piantanida, M. (2010). Grounded theory in genetic counseling research: an interpretive perspective. Journal of Genetic Counseling, 19(2), 99–111.PubMedCrossRef Grubs, R., & Piantanida, M. (2010). Grounded theory in genetic counseling research: an interpretive perspective. Journal of Genetic Counseling, 19(2), 99–111.PubMedCrossRef
go back to reference Hallowell, N., Foster, C., Ardern-Jones, A., Eeles, R., Murday, V., & Watson, M. (2002). Genetic testing for women previously diagnosed with breast/ovarian cancer: examining the impact of BRCA1 and BRCA2 mutation searching. Genetic Testing, 6(2), 79–87.PubMedCrossRef Hallowell, N., Foster, C., Ardern-Jones, A., Eeles, R., Murday, V., & Watson, M. (2002). Genetic testing for women previously diagnosed with breast/ovarian cancer: examining the impact of BRCA1 and BRCA2 mutation searching. Genetic Testing, 6(2), 79–87.PubMedCrossRef
go back to reference Hamilton, R., & Bowers, B. (2007). The theory of genetic vulnerability: a Roy model exemplar. Nursing Science Quarterly, 20(3), 254–264.PubMedCrossRef Hamilton, R., & Bowers, B. (2007). The theory of genetic vulnerability: a Roy model exemplar. Nursing Science Quarterly, 20(3), 254–264.PubMedCrossRef
go back to reference Harper, P. S. (1991). Huntington disease. London: WB Saunders. Harper, P. S. (1991). Huntington disease. London: WB Saunders.
go back to reference Herishanu, Y. O., Parvari, R., Pollack, Y., Shelef, I., Marom, B., Martino, T., et al. (2009). Huntington disease in subjects from an Israeli Karaite community carrying alleles of intermediate and expanded CAG repeats in the HTT gene: Huntington disease or phenocopy? Journal of the Neurological Sciences, 277(1–2), 143–146.PubMedCrossRef Herishanu, Y. O., Parvari, R., Pollack, Y., Shelef, I., Marom, B., Martino, T., et al. (2009). Huntington disease in subjects from an Israeli Karaite community carrying alleles of intermediate and expanded CAG repeats in the HTT gene: Huntington disease or phenocopy? Journal of the Neurological Sciences, 277(1–2), 143–146.PubMedCrossRef
go back to reference Huntington, G. (1872). On chorea. The Medical and Surgical Reporter: A Weekly Journal, 26(15), 317–321. Huntington, G. (1872). On chorea. The Medical and Surgical Reporter: A Weekly Journal, 26(15), 317–321.
go back to reference International Huntington disease Association & World Federation of Neurology Research Group on Huntington’s Chorea. (1994). Guidelines for the molecular genetics predictive test in Huntington’s disease. Neurology, 44(8), 1533–1536.CrossRef International Huntington disease Association & World Federation of Neurology Research Group on Huntington’s Chorea. (1994). Guidelines for the molecular genetics predictive test in Huntington’s disease. Neurology, 44(8), 1533–1536.CrossRef
go back to reference Kenney, C., Powell, S., & Jankovic, J. (2007). Autopsy-proven Huntington’s disease with 29 trinucleotide repeats. Movement Disorders, 22(1), 127–130.PubMedCrossRef Kenney, C., Powell, S., & Jankovic, J. (2007). Autopsy-proven Huntington’s disease with 29 trinucleotide repeats. Movement Disorders, 22(1), 127–130.PubMedCrossRef
go back to reference Kremer, B., Goldberg, P., Andrew, S. E., Theilmann, J., Telenius, H., Zeisler, J., et al. (1994). A worldwide study of the Huntington’s disease mutation. The sensitivity and specificity of measuring CAG repeats. New England Journal of Medicine, 330(20), 1401–1406.PubMedCrossRef Kremer, B., Goldberg, P., Andrew, S. E., Theilmann, J., Telenius, H., Zeisler, J., et al. (1994). A worldwide study of the Huntington’s disease mutation. The sensitivity and specificity of measuring CAG repeats. New England Journal of Medicine, 330(20), 1401–1406.PubMedCrossRef
go back to reference Laccone, F., Engel, U., Holinski-Feder, E., Weigell-Weber, M., Marczinek, K., Nolte, D., et al. (1999). DNA analysis of Huntington’s disease: five years of experience in Germany, Austria, and Switzerland. Neurology, 53(4), 801–806.PubMedCrossRef Laccone, F., Engel, U., Holinski-Feder, E., Weigell-Weber, M., Marczinek, K., Nolte, D., et al. (1999). DNA analysis of Huntington’s disease: five years of experience in Germany, Austria, and Switzerland. Neurology, 53(4), 801–806.PubMedCrossRef
go back to reference Maat-Kievit, A., Vegter-van der Vlis, M., Zoeteweij, M., Losekoot, M., van Haeringen, A., & Roos, R. (2000). Paradox of a better test for Huntington’s disease. Journal of Neurology, Neurosurgery, and Psychiatry, 69(5), 579–583.PubMedPubMedCentralCrossRef Maat-Kievit, A., Vegter-van der Vlis, M., Zoeteweij, M., Losekoot, M., van Haeringen, A., & Roos, R. (2000). Paradox of a better test for Huntington’s disease. Journal of Neurology, Neurosurgery, and Psychiatry, 69(5), 579–583.PubMedPubMedCentralCrossRef
go back to reference Maat-Kievit, A., Losekoot, M., Van Den Boer-Van Den Berg, H., Van Ommen, G. J., Niermeijer, M., Breuning, M., et al. (2001). New problems in testing for Huntington’s disease: the issue of intermediate and reduced penetrance alleles. Journal of Medical Genetics, 38(4), E12.PubMedPubMedCentralCrossRef Maat-Kievit, A., Losekoot, M., Van Den Boer-Van Den Berg, H., Van Ommen, G. J., Niermeijer, M., Breuning, M., et al. (2001). New problems in testing for Huntington’s disease: the issue of intermediate and reduced penetrance alleles. Journal of Medical Genetics, 38(4), E12.PubMedPubMedCentralCrossRef
go back to reference Maheu, C., & Thorne, S. (2008). Receiving inconclusive genetic test results: an interpretive description of the BRCA1/2 experience. Research in Nursing & Health, 31(6), 553–562.CrossRef Maheu, C., & Thorne, S. (2008). Receiving inconclusive genetic test results: an interpretive description of the BRCA1/2 experience. Research in Nursing & Health, 31(6), 553–562.CrossRef
go back to reference McAllister, M. (2001). Grounded theory in genetic counseling research. Journal of Genetic Counseling, 10(3), 233–250.CrossRef McAllister, M. (2001). Grounded theory in genetic counseling research. Journal of Genetic Counseling, 10(3), 233–250.CrossRef
go back to reference McCusker, E. A., Casse, R. F., Graham, S. J., Williams, D. B., & Lazarus, R. (2000). Prevalence of Huntington disease in New South Wales in 1996. Medical Journal of Australia, 173(4), 187–190.PubMedCrossRef McCusker, E. A., Casse, R. F., Graham, S. J., Williams, D. B., & Lazarus, R. (2000). Prevalence of Huntington disease in New South Wales in 1996. Medical Journal of Australia, 173(4), 187–190.PubMedCrossRef
go back to reference Potter, N. T., Spector, E. B., & Prior, T. W. (2004). Technical standards and guidelines for Huntington disease testing. Genetics in Medicine, 6(1), 61–65.PubMedCrossRef Potter, N. T., Spector, E. B., & Prior, T. W. (2004). Technical standards and guidelines for Huntington disease testing. Genetics in Medicine, 6(1), 61–65.PubMedCrossRef
go back to reference Ramos-Arroyo, M. A., Moreno, S., & Valiente, A. (2005). Incidence and mutation rates of Huntington’s disease in Spain: experience of 9 years of direct genetic testing. Journal of Neurology, Neurosurgery, and Psychiatry, 76(3), 337–42.PubMedPubMedCentralCrossRef Ramos-Arroyo, M. A., Moreno, S., & Valiente, A. (2005). Incidence and mutation rates of Huntington’s disease in Spain: experience of 9 years of direct genetic testing. Journal of Neurology, Neurosurgery, and Psychiatry, 76(3), 337–42.PubMedPubMedCentralCrossRef
go back to reference Semaka, A., Creighton, S., Warby, S., & Hayden, M. R. (2006). Predictive testing for Huntington disease: interpretation and significance of intermediate alleles. Clinical Genetics, 70(4), 283–294.PubMedCrossRef Semaka, A., Creighton, S., Warby, S., & Hayden, M. R. (2006). Predictive testing for Huntington disease: interpretation and significance of intermediate alleles. Clinical Genetics, 70(4), 283–294.PubMedCrossRef
go back to reference Sequeiros, J., Ramos, E. M., Cerqueira, J., Costa, M. C., Sousa, A., Pinto-Basto, J., et al. (2010). Large normal and reduced penetrance alleles in Huntington disease: instability in families and frequency at the laboratory, at the clinic and in the population. Clinical Genetics, 78(4), 381–387.PubMedCrossRef Sequeiros, J., Ramos, E. M., Cerqueira, J., Costa, M. C., Sousa, A., Pinto-Basto, J., et al. (2010). Large normal and reduced penetrance alleles in Huntington disease: instability in families and frequency at the laboratory, at the clinic and in the population. Clinical Genetics, 78(4), 381–387.PubMedCrossRef
go back to reference Strauss, A., & Corbin, J. (1998). Basics of qualitative research: Grounded theory procedures and techniques. Thousand Oaks: Sage Publications. Strauss, A., & Corbin, J. (1998). Basics of qualitative research: Grounded theory procedures and techniques. Thousand Oaks: Sage Publications.
go back to reference Tassicker, R. J., Marshall, P. K., Liebeck, T. A., Keville, M. A., Singaram, B. M., & Richards, F. H. (2006). Predictive and pre-natal testing for Huntington Disease in Australia: results and challenges encountered during a 10-year period (1994-2003). Clinical Genetics, 70(6), 480–489.PubMedCrossRef Tassicker, R. J., Marshall, P. K., Liebeck, T. A., Keville, M. A., Singaram, B. M., & Richards, F. H. (2006). Predictive and pre-natal testing for Huntington Disease in Australia: results and challenges encountered during a 10-year period (1994-2003). Clinical Genetics, 70(6), 480–489.PubMedCrossRef
go back to reference Telenius, H., Kremer, H. P., Theilmann, J., Andrew, S. E., Almqvist, E., Anvret, M., et al. (1993). Molecular analysis of juvenile Huntington disease: the major influence on (CAG)n repeat length is the sex of the affected parent. Human Molecular Genetics, 2(10), 1535–1540.PubMedCrossRef Telenius, H., Kremer, H. P., Theilmann, J., Andrew, S. E., Almqvist, E., Anvret, M., et al. (1993). Molecular analysis of juvenile Huntington disease: the major influence on (CAG)n repeat length is the sex of the affected parent. Human Molecular Genetics, 2(10), 1535–1540.PubMedCrossRef
go back to reference The Huntington’s Disease Collaborative Research Group. (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell, 72(6), 971–983.CrossRef The Huntington’s Disease Collaborative Research Group. (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell, 72(6), 971–983.CrossRef
go back to reference van den Boer-van den Berg, H. M., & Maat-Kievit, A. A. (2001). The whole truth and nothing but the truth, but what is the truth? Journal of Medical Genetics, 38(1), 39–42.PubMedCrossRef van den Boer-van den Berg, H. M., & Maat-Kievit, A. A. (2001). The whole truth and nothing but the truth, but what is the truth? Journal of Medical Genetics, 38(1), 39–42.PubMedCrossRef
go back to reference van Dijk, S., Otten, W., Timmermans, D. R. M., van Asperen, C. J., Meijers-Heijboer, H., Tibben, A., et al. (2005). What’s the message? Interpretation of an uninformative BRCA1/2 test result for women at risk of familial breast cancer. Genetics in Medicine, 7(4), 239–245.PubMedCrossRef van Dijk, S., Otten, W., Timmermans, D. R. M., van Asperen, C. J., Meijers-Heijboer, H., Tibben, A., et al. (2005). What’s the message? Interpretation of an uninformative BRCA1/2 test result for women at risk of familial breast cancer. Genetics in Medicine, 7(4), 239–245.PubMedCrossRef
go back to reference van Dijk, S., Timmermans, D. R. M., Meijers-Heijboer, H., Tibben, A., van Asperen, C. J., & Otten, W. (2006). Clinical characteristics affect the impact of an uninformative DNA test result: the course of worry and distress experienced by women who apply for genetic testing for breast cancer. Journal of Clinical Oncology, 24(22), 3672–3677.PubMedCrossRef van Dijk, S., Timmermans, D. R. M., Meijers-Heijboer, H., Tibben, A., van Asperen, C. J., & Otten, W. (2006). Clinical characteristics affect the impact of an uninformative DNA test result: the course of worry and distress experienced by women who apply for genetic testing for breast cancer. Journal of Clinical Oncology, 24(22), 3672–3677.PubMedCrossRef
go back to reference van Dijk, S., Otten, W., Tollenaar, R. A. E. M., van Asperen, C. J., & Tibben, A. (2008). Putting it all behind: long-term psychological impact of an inconclusive DNA test result for breast cancer. Genetics in Medicine, 10(10), 745–750.PubMedCrossRef van Dijk, S., Otten, W., Tollenaar, R. A. E. M., van Asperen, C. J., & Tibben, A. (2008). Putting it all behind: long-term psychological impact of an inconclusive DNA test result for breast cancer. Genetics in Medicine, 10(10), 745–750.PubMedCrossRef
Metadata
Title
“Grasping the Grey”: Patient Understanding and Interpretation of an Intermediate Allele Predictive Test Result for Huntington Disease
Authors
A. Semaka
L. G. Balneaves
M. R. Hayden
Publication date
01-04-2013
Publisher
Springer US
Published in
Journal of Genetic Counseling / Issue 2/2013
Print ISSN: 1059-7700
Electronic ISSN: 1573-3599
DOI
https://doi.org/10.1007/s10897-012-9533-7

Other articles of this Issue 2/2013

Journal of Genetic Counseling 2/2013 Go to the issue